Nisa Investment Advisors’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.71K Sell
6,220
-2,421
-28% -$3K ﹤0.01% 2359
2025
Q1
$10.2K Buy
8,641
+7,752
+872% +$9.15K ﹤0.01% 2089
2024
Q4
$1.63K Sell
889
-9,609
-92% -$17.6K ﹤0.01% 2557
2024
Q3
$17.8K Buy
10,498
+1,423
+16% +$2.42K ﹤0.01% 1944
2024
Q2
$12.4K Buy
9,075
+772
+9% +$1.06K ﹤0.01% 2080
2024
Q1
$31.1K Sell
8,303
-153,955
-95% -$577K ﹤0.01% 1765
2023
Q4
$1.59M Sell
162,258
-135
-0.1% -$1.32K 0.01% 722
2023
Q3
$1.36M Buy
162,393
+135
+0.1% +$1.13K 0.01% 784
2023
Q2
$2.16M Buy
162,258
+540
+0.3% +$7.18K 0.02% 657
2023
Q1
$1.87M Sell
161,718
-850
-0.5% -$9.85K 0.01% 681
2022
Q4
$1.33M Hold
162,568
0.01% 836
2022
Q3
$1.09M Buy
162,568
+153,890
+1,773% +$1.03M 0.01% 784
2022
Q2
$38K Buy
8,678
+1,873
+28% +$8.2K ﹤0.01% 1826
2022
Q1
$62K Buy
6,805
+280
+4% +$2.55K ﹤0.01% 1777
2021
Q4
$73K Sell
6,525
-677
-9% -$7.57K ﹤0.01% 1621
2021
Q3
$184 Sell
7,202
-5,291
-42% -$135 ﹤0.01% 1436
2021
Q2
$437 Hold
12,493
﹤0.01% 1166
2021
Q1
$416 Sell
12,493
-385
-3% -$13 ﹤0.01% 1218
2020
Q4
$334K Buy
12,878
+4,193
+48% +$109K ﹤0.01% 1295
2020
Q3
$86K Buy
8,685
+6,250
+257% +$61.9K ﹤0.01% 1589
2020
Q2
$8K Sell
2,435
-38,685
-94% -$127K ﹤0.01% 1959
2020
Q1
$126K Buy
41,120
+1,620
+4% +$4.96K ﹤0.01% 1313
2019
Q4
$203K Hold
39,500
﹤0.01% 1323
2019
Q3
$204K Buy
+39,500
New +$204K ﹤0.01% 1319
2017
Q1
Sell
-1,700
Closed -$6K 1888
2016
Q4
$6K Hold
1,700
﹤0.01% 1842
2016
Q3
$15K Buy
+1,700
New +$15K ﹤0.01% 1734